Keltech Energies Limited (KELENRG.BO)
Bangalore, IN
Keltech Energies Limited primarily operates within the industrial explosives industry. The company's activities are organized into two key divisions: Explosives and Perlite. The Explosives division specializes in the manufacturing of both cartridge and bulk emulsion explosives. Conversely, the Perlite division is responsible for creating products such as cryogenic insulation, industrial filter-aids, and horticultural supplies. Founded on August 30, 1977, the firm is headquartered in Bangalore, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.33% | -3.14% | +12.78% | +52.19% | +20.63% | +32.58% | +41.34% | +182.34% | +750.07% | +945.15% | +27,073.89% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-01 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Industrial - Specialties: +7.4%+7.3% Q1'26: +0.9% (vs Q1'25)
-
EPS growth Industrial - Specialties: +14.1%+14.9% ★ Q1'26: +22.7% (vs Q1'25)
-
FCF margin FCF growth · Industrial - Specialties: +45.6%+4.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Industrial - Specialties: +10.1%+6.3% Q1'26: +6.0% (vs Q1'25)
-
ROIC Industrial - Specialties: +6.4%+12.7% ★ Q1'26: +13.0% (vs Q1'25)
-
Share dilution Industrial - Specialties: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Specialties: -0.19×1.79× Q1'26: 1.72× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
Mar 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.92B
est: 1.55B (+24.2%)
|
1.79B
est: 1.92B (-6.5%)
|
2.01B
est: 1.90B (+5.7%)
|
2.02B
est: 2.15B (-6.0%)
|
2.26B
est: 2.37B (-4.4%)
|
2.16B
est: 2.27B (-5.1%)
|
2.20B
est: 2.48B (-11.2%)
|
4.96B
est: 1.92B (+158.2%)
|
1.92B
1.92B – 1.92B
+0.0% YoY
|
1.90B
1.90B – 1.90B
-0.9% YoY
|
2.15B
2.15B – 2.15B
+13.1% YoY
|
2.37B
2.37B – 2.37B
+10.0% YoY
|
2.27B
2.27B – 2.27B
-3.9% YoY
|
2.48B
2.48B – 2.48B
+9.0% YoY
|
| EBITDA |
118.59M
est: 96.89M (+22.4%)
|
136.29M
est: 120.36M (+13.2%)
|
165.00M
est: 119.27M (+38.3%)
|
193.19M
est: 134.86M (+43.2%)
|
155.59M
est: 148.36M (+4.9%)
|
142.33M
est: 142.63M (-0.2%)
|
107.09M
est: 155.47M (-31.1%)
|
442.77M
est: 131.19M (+237.5%)
|
131.19M
131.19M – 131.19M
+0.0% YoY
|
130.00M
130.00M – 130.00M
-0.9% YoY
|
147.00M
147.00M – 147.00M
+13.1% YoY
|
161.71M
161.71M – 161.71M
+10.0% YoY
|
155.46M
155.46M – 155.46M
-3.9% YoY
|
169.46M
169.46M – 169.46M
+9.0% YoY
|
| EBIT |
74.31M
est: 72.18M (+2.9%)
|
97.65M
est: 89.67M (+8.9%)
|
112.83M
est: 88.86M (+27.0%)
|
137.57M
est: 100.48M (+36.9%)
|
101.46M
est: 110.53M (-8.2%)
|
86.63M
est: 106.26M (-18.5%)
|
53.46M
est: 115.83M (-53.8%)
|
372.80M
est: 104.34M (+257.3%)
|
104.34M
104.34M – 104.34M
+0.0% YoY
|
103.40M
103.40M – 103.40M
-0.9% YoY
|
116.91M
116.91M – 116.91M
+13.1% YoY
|
128.61M
128.61M – 128.61M
+10.0% YoY
|
123.65M
123.65M – 123.65M
-3.9% YoY
|
134.77M
134.77M – 134.77M
+9.0% YoY
|
| Net Income |
34.19M
est: 59.48M (-42.5%)
|
50.69M
est: 34.19M (+48.3%)
|
58.39M
est: 50.86M (+14.8%)
|
75.54M
est: 117.96M (-36.0%)
|
60.25M
est: 127.42M (-52.7%)
|
47.39M
est: 117.76M (-59.8%)
|
18.76M
est: 132.06M (-85.8%)
|
249.41M
est: 34.19M (+629.5%)
|
34.19M
34.19M – 34.19M
+0.0% YoY
|
50.86M
50.86M – 50.86M
+48.8% YoY
|
117.96M
117.96M – 117.96M
+131.9% YoY
|
127.42M
127.42M – 127.42M
+8.0% YoY
|
117.76M
117.76M – 117.76M
-7.6% YoY
|
132.06M
132.06M – 132.06M
+12.1% YoY
|
| SGA |
66.97M
est: 103.10M (-35.0%)
|
35.23M
est: 128.07M (-72.5%)
|
177.41M
est: 126.92M (+39.8%)
|
177.22M
est: 143.51M (+23.5%)
|
210.66M
est: 157.86M (+33.4%)
|
222.73M
est: 151.77M (+46.8%)
|
215.35M
est: 165.43M (+30.2%)
|
335.66M
est: 150.44M (+123.1%)
|
150.44M
150.44M – 150.44M
+0.0% YoY
|
149.08M
149.08M – 149.08M
-0.9% YoY
|
168.57M
168.57M – 168.57M
+13.1% YoY
|
185.43M
185.43M – 185.43M
+10.0% YoY
|
178.28M
178.28M – 178.28M
-3.9% YoY
|
194.32M
194.32M – 194.32M
+9.0% YoY
|
| EPS |
34.19
est: 59.48 (-42.5%)
|
50.69
est: 34.19 (+48.3%)
|
58.39
est: 50.86 (+14.8%)
|
75.54
est: 117.96 (-36.0%)
|
60.26
est: 127.42 (-52.7%)
|
47.40
est: 117.76 (-59.7%)
|
18.76
est: 132.06 (-85.8%)
|
249.41
est: 34.19 (+629.5%)
|
34.19
34.19 – 34.19
+0.0% YoY
|
50.86
50.86 – 50.86
+48.8% YoY
|
117.96
117.96 – 117.96
+131.9% YoY
|
127.42
127.42 – 127.42
+8.0% YoY
|
117.76
117.76 – 117.76
-7.6% YoY
|
132.06
132.06 – 132.06
+12.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 4/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 3/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mahesh Vijay Wataney | MD & Director | 23M | male |
| Santosh Laxmanrao Chowgule | Executive Vice Chairman | 17M | male |
| K. Indrasen Reddy | Business Head (Explosives) | — | male |
| Prabhudev Paramashivaiah | Chief Financial Officer | — | male |
| Rachana Kanhaiyalal Salavant | Company Secretary & Compliance Officer | — | female |
| Sujay Sukumar | Chief Operating Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KELENRG.BO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
